Advertisement

Ads Placeholder
Loading...

Inventiva S.A.

IVA.PAEURONEXT
Healthcare
Biotechnology
4.72
0.14(3.17%)
U.S. Market opens in 55h 43m

Inventiva S.A. Fundamental Analysis

Inventiva S.A. (IVA.PA) shows weak financial fundamentals with a PE ratio of -1.65, profit margin of -18.92%, and ROE of 5.36%. The company generates $0.0B in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

Cash Position23.76%
PEG Ratio0.07
Current Ratio2.95

Areas of Concern

ROE5.36%
Operating Margin-6.21%
We analyze IVA.PA's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -1655.2/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-1655.2/100

We analyze IVA.PA's fundamental strength across five key dimensions:

Efficiency Score

Weak

IVA.PA struggles to generate sufficient returns from assets.

ROA > 10%
-1.74%

Valuation Score

Excellent

IVA.PA trades at attractive valuation levels.

PE < 25
-1.65
PEG Ratio < 2
0.07

Growth Score

Weak

IVA.PA faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Excellent

IVA.PA maintains a strong and stable balance sheet.

Debt/Equity < 1
-6.11
Current Ratio > 1
2.95

Profitability Score

Weak

IVA.PA struggles to sustain strong margins.

ROE > 15%
5.36%
Net Margin ≥ 15%
-18.92%
Positive Free Cash Flow
No

Key Financial Metrics

Is IVA.PA Expensive or Cheap?

P/E Ratio

IVA.PA trades at -1.65 times earnings. This suggests potential undervaluation.

-1.65

PEG Ratio

When adjusting for growth, IVA.PA's PEG of 0.07 indicates potential undervaluation.

0.07

Price to Book

The market values Inventiva S.A. at -54.97 times its book value. This may indicate undervaluation.

-54.97

EV/EBITDA

Enterprise value stands at -3.40 times EBITDA. This is generally considered low.

-3.40

How Well Does IVA.PA Make Money?

Net Profit Margin

For every $100 in sales, Inventiva S.A. keeps $-18.92 as profit after all expenses.

-18.92%

Operating Margin

Core operations generate -6.21 in profit for every $100 in revenue, before interest and taxes.

-6.21%

ROE

Management delivers $5.36 in profit for every $100 of shareholder equity.

5.36%

ROA

Inventiva S.A. generates $-1.74 in profit for every $100 in assets, demonstrating efficient asset deployment.

-1.74%

Following the Money - Real Cash Generation

Operating Cash Flow

Inventiva S.A. generates limited operating cash flow of $-178.65M, signaling weaker underlying cash strength.

$-178.65M

Free Cash Flow

Inventiva S.A. generates weak or negative free cash flow of $-179.14M, restricting financial flexibility.

$-179.14M

FCF Per Share

Each share generates $-1.29 in free cash annually.

$-1.29

FCF Yield

IVA.PA converts -21.36% of its market value into free cash.

-21.36%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-1.65

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

0.07

vs 25 benchmark

P/B Ratio

Price to book value ratio

-54.97

vs 25 benchmark

P/S Ratio

Price to sales ratio

39.92

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

-6.11

vs 25 benchmark

Current Ratio

Current assets to current liabilities

2.95

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

5.36

vs 25 benchmark

ROA

Return on assets percentage

-1.74

vs 25 benchmark

ROCE

Return on capital employed

-0.85

vs 25 benchmark

How IVA.PA Stacks Against Its Sector Peers

MetricIVA.PA ValueSector AveragePerformance
P/E Ratio-1.6528.45 Better (Cheaper)
ROE536.36%763.00% Weak
Net Margin-1891.66%-45265.00% (disorted) Weak
Debt/Equity-6.110.34 Strong (Low Leverage)
Current Ratio2.952795.60 Strong Liquidity
ROA-174.25%-16588.00% (disorted) Weak

IVA.PA outperforms its industry in 3 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Inventiva S.A.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ